Prenatal gene therapy has been used to prevent acute neuronopathic Gaucher’s disease, however this approach is using viruses to deliver normal copies of genes.
The Nuffield Council on Bioethics has concluded that using gene editing tools on human embryos, sperm, or eggs for heritable gene editing could be ‘morally permissible’ in some cases.
CRISPR gene drives have been tested in laboratory mice for the first time, offering a way in which multiple genes in mice can be altered to model complex multigenic human diseases. Could this step eventually lead to the eradication of pest species or is the technology still too controversial?
Founded in 1790, the Patent Office aimed to put innovation and entrepreneurship within reach of every citizen. Now, 10 million patents later, critics say an out-of-touch system is doing the opposite.
Francisco Ayala, a renowned evolutionary biologist at the University of California, Irvine, has resigned his position after an investigation into sexual harassment allegations against him.
The “Born in Guangzhou Cohort Study” is looking to recruit 50,000 baby-mother sets by 2020. Since 2012, 1.6 million samples have been collected for the project and the some of the first findings have been published.
Cancer Research UK Cambridge Institute is pushing for the use of genetic testing to transform treatment of breast cancer with the Personalised Breast Cancer Programme.
A report has highlighted the potential misuses of synthetic biology for biological warfare with recommendations of how we might prepare for and prevent biological attacks.
Travel allows us to see the world – and bring foreign diseases home. Here’s why spreading disease is easier than ever.
Digital health devices have become invaluable tools for improving human health. However, could a pill carrying an inbuilt sensor dehumanize patients, reducing them to a digital readout?